Nippon Kayaku Co., Ltd.

4272

JP3694400007

Diversified Chemicals

Delayed Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
1,254 ^JPY	+0.52%		0.00%	-6.76%

Apr. 25	Nippon Kayaku to Book Extraordinary Loss of 2.56 Billion Yen in Fiscal 2024	MT
Feb. 07	Nippon Kayaku Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Ending March 31, 2024	CI

Nippon Kayaku Co., Ltd. Provides Dividend Guidance for the Fiscal Ending March 31, 2024

February 06, 2024 at 08:00 pm EST

Nippon Kayaku Co., Ltd. provided dividend guidance for the fiscal ending March 31, 2024. For the full year, the company expects to pay a dividend of ¥22.50 against ¥25 paid last year.

Latest news about Nippon Kayaku Co., Ltd.

Nippon Kayaku to Book Extraordinary Loss of 2.56 Billion Yen in Fiscal 2024	Apr. 24	MT
Nippon Kayaku Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Ending March 31, 2024	Feb. 06	CI
BioCheetah Pte. Ltd. Announces Exclusive Licensing and Commercialization Agreement with Nippon Kayaku Co., Ltd. for VECanDx in Japan	Dec. 14	CI
Nippon Kayaku Co., Ltd. and AnHeart Therapeutics Inc. Enter into Licensing Agreement	23-10-31	CI
Nippon Kayaku Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	23-10-31	CI
Nippon Kayaku Co., Ltd. Revises Consolidated Earnings Guidance for the Six Months Ended September 30, 2023	23-10-31	CI
Adlai Nortye Ltd. announced that it has received $40 million in funding from Nippon Kayaku Co., Ltd.	23-10-02	CI
Nippon Kayaku Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Ending March 31, 2024	23-08-03	CI
Nippon Kayaku Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-15	CI
Nippon Kayaku Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Ending March 31, 2024	23-05-14	CI
SkyDrive Inc. announced that it has received funding from a group of investors	23-04-05	CI
Tranche Update on Nippon Kayaku Co., Ltd.'s Equity Buyback Plan announced on November 8, 2022.	23-03-22	CI
Nippon Kayaku Co., Ltd.'s Equity Buyback announced on November 8, 2022, has closed with 2,561,500 shares, representing 1.53% for Â¥2,999.93 million.	23-03-15	CI
Nippon Kayaku Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	23-02-02	CI
Tranche Update on Nippon Kayaku Co., Ltd.'s Equity Buyback Plan announced on November 8, 2022.	23-01-09	CI
Nippon Kayaku Launches Over $21 Million Share Buyback Program	22-11-14	MT
Nippon Kayaku Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	22-11-11	CI
Nippon Kayaku Co., Ltd. authorizes a Buyback Plan.	22-11-07	CI
Nippon Kayaku Co., Ltd. announces an Equity Buyback for 3,000,000 shares, representing 1.78% for ¥3,000 million.	22-11-07	CI
SkyDrive Inc. announced that it expects to receive funding from a group of investors	22-09-25	CI
Solasia Launches Anticancer Injection Darvias	22-08-23	MT
Nippon Kayaku Co., Ltd. Provides Earnings Guidance for the First Half of Fiscal Year 2023 and for the Full Year Ending March 31, 2023	22-08-03	CI
Solasia Pharma K.K. announced that it has received Ã‘1.02 billion in funding from Nippon Kayaku Co., Ltd.	22-07-13	CI
Solasia to Sell Nearly 8% Interest to Nippon Kayaku for $7.5 Million	22-06-29	MT
Solasia Pharma K.K. announced that it expects to receive Ã‘1.02 billion in funding from Nippon Kayaku Co., Ltd.	22-06-27	CI

NIPPON KAYAKU CO., LTD. is primarily engaged in the manufacture and sale of functional chemical products. The Company has three business segments. The Functional Chemical segment manufactures and sells functional materials, such as epoxy resin, ultraviolet curable resin and high-performance chemicals; pigment materials, including functional dyes, pigment for inkjet printers and others; catalysts, such as catalysts for acrylic and methacrylic acid manufacturing, as well as coloring materials, such as dyes and special coloring materials for nonfibrous products, among others. The Pharmaceutical segment supplies pharmaceutical products, medical intermediates and diagnostic medicines, among others. The Safety Systems segment provides inflators for airbags and micro gas generators for seatbelt pretensioners. The Company is also engaged in the manufacture and sale of agricultural chemicals.

Sector

Diversified Chemicals

Calendar

2024-05-12 - Q4 2024 Earnings Release

More about the company

	1st Jan change	Capi.
NIPPON KAYAKU CO., LTD.	-6.76%	1.32B
SHIN-ETSU CHEMICAL CO., LTD.	-0.19%	74.89B
BASF SE	+0.09%	46.52B
DUPONT DE NEMOURS, INC.	-4.19%	30.82B
PIDILITE INDUSTRIES LIMITED	+10.64%	18.19B
BRENNTAG SE	-10.05%	11.54B
EASTMAN CHEMICAL COMPANY	+6.39%	11.24B
SYENSQO SA/NV	-8.09%	9.73B
ASAHI KASEI CORPORATION	+2.79%	9.4B
SRF LIMITED	+6.28%	9.37B

Diversified Chemicals